Lin MH, Weiss J, Phillips TJ, Sano D, et al. Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphoma. Leuk Lymphoma 2025 Jun 9:1-13. doi: 10.1080/10428194.2025.2506498.
PMID: 40488632